Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

133 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
A Phase Ib Trial of Personalized Neoantigen Therapy Plus Anti-PD-1 in Patients with Advanced Melanoma, Non-small Cell Lung Cancer, or Bladder Cancer.
Ott PA, Hu-Lieskovan S, Chmielowski B, Govindan R, Naing A, Bhardwaj N, Margolin K, Awad MM, Hellmann MD, Lin JJ, Friedlander T, Bushway ME, Balogh KN, Sciuto TE, Kohler V, Turnbull SJ, Besada R, Curran RR, Trapp B, Scherer J, Poran A, Harjanto D, Barthelme D, Ting YS, Dong JZ, Ware Y, Huang Y, Huang Z, Wanamaker A, Cleary LD, Moles MA, Manson K, Greshock J, Khondker ZS, Fritsch E, Rooney MS, DeMario M, Gaynor RB, Srinivasan L. Ott PA, et al. Among authors: kohler v. Cell. 2020 Oct 15;183(2):347-362.e24. doi: 10.1016/j.cell.2020.08.053. Cell. 2020. PMID: 33064988 Free article. Clinical Trial.
Personalized neoantigen vaccine NEO-PV-01 with chemotherapy and anti-PD-1 as first-line treatment for non-squamous non-small cell lung cancer.
Awad MM, Govindan R, Balogh KN, Spigel DR, Garon EB, Bushway ME, Poran A, Sheen JH, Kohler V, Esaulova E, Srouji J, Ramesh S, Vyasamneni R, Karki B, Sciuto TE, Sethi H, Dong JZ, Moles MA, Manson K, Rooney MS, Khondker ZS, DeMario M, Gaynor RB, Srinivasan L. Awad MM, et al. Among authors: kohler v. Cancer Cell. 2022 Sep 12;40(9):1010-1026.e11. doi: 10.1016/j.ccell.2022.08.003. Epub 2022 Aug 25. Cancer Cell. 2022. PMID: 36027916 Free article. Clinical Trial.
A universal MHCII technology platform to characterize antigen-specific CD4+ T cells.
Vyasamneni R, Kohler V, Karki B, Mahimkar G, Esaulova E, McGee J, Kallin D, Sheen JH, Harjanto D, Kirsch M, Poran A, Dong J, Srinivasan L, Gaynor RB, Bushway ME, Srouji JR. Vyasamneni R, et al. Among authors: kohler v. Cell Rep Methods. 2023 Jan 13;3(1):100388. doi: 10.1016/j.crmeth.2022.100388. eCollection 2023 Jan 23. Cell Rep Methods. 2023. PMID: 36814840 Free PMC article.
Highly sensitive single-molecule detection of macromolecule ion beams.
Strauß M, Shayeghi A, Mauser MFX, Geyer P, Kostersitz T, Salapa J, Dobrovolskiy O, Daly S, Commandeur J, Hua Y, Köhler V, Mayor M, Benserhir J, Bruschini C, Charbon E, Castaneda M, Gevers M, Gourgues R, Kalhor N, Fognini A, Arndt M. Strauß M, et al. Among authors: kohler v. Sci Adv. 2023 Dec;9(48):eadj2801. doi: 10.1126/sciadv.adj2801. Epub 2023 Dec 1. Sci Adv. 2023. PMID: 38039360 Free PMC article.
Giving the Green Light to Photochemical Uncaging of Large Biomolecules in High Vacuum.
Hua Y, Strauss M, Fisher S, Mauser MFX, Manchet P, Smacchia M, Geyer P, Shayeghi A, Pfeffer M, Eggenweiler TH, Daly S, Commandeur J, Mayor M, Arndt M, Šolomek T, Köhler V. Hua Y, et al. Among authors: kohler v. JACS Au. 2023 Oct 16;3(10):2790-2799. doi: 10.1021/jacsau.3c00351. eCollection 2023 Oct 23. JACS Au. 2023. PMID: 37885583 Free PMC article.
Early fate decision for mitochondrially encoded proteins by a molecular triage.
Kohler A, Carlström A, Nolte H, Kohler V, Jung SJ, Sridhara S, Tatsuta T, Berndtsson J, Langer T, Ott M. Kohler A, et al. Among authors: kohler v. Mol Cell. 2023 Oct 5;83(19):3470-3484.e8. doi: 10.1016/j.molcel.2023.09.001. Epub 2023 Sep 25. Mol Cell. 2023. PMID: 37751741 Free article.
133 results